Literature DB >> 9634530

Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH.

K Woodward1, E Kendall, D Vetrie, S Malcolm.   

Abstract

Pelizaeus-Merzbacher disease (PMD) is an X-linked, dysmyelinating disorder of the CNS. Duplications of the proteolipid protein (PLP) gene have been found in a proportion of patients, suggesting that, in addition to coding-region or splice-site mutations, overdosage of the gene can cause PMD. We show that the duplication can be detected by interphase FISH, using a PLP probe in five patients and their four asymptomatic carrier mothers. The extent of the duplication was analyzed in each family by interphase FISH, with probes from a 1. 7-Mb region surrounding the PLP gene between markers DXS83 and DXS94. A large duplication >=500 kb was detected, with breakpoints that differed, between families, at the proximal end. Distinct separation of the duplicated PLP signals could be seen only on metaphase chromosomes in one family, providing further evidence that different duplication events are involved. Quantitative fluorescent multiplex PCR was used to confirm the duplication in patients, by the detection of increased copy number of the PLP gene. Multiallelic markers from the duplicated region were analyzed, since the identification of two alleles in an affected boy would indicate a duplication. The majority of boys were homozygous for all four markers, compared with their mothers, who were heterozygous for one to three of the markers. These results suggest that intrachromosomal rearrangements may be a common mechanism by which duplications arise in PMD. One boy was heterozygous for the PLP marker, indicating a duplication and suggesting that interchromosomal rearrangements of maternal origin also can be involved. Since duplications are a major cause of PMD, we propose that interphase FISH is a reliable method for diagnosis and identification of female carriers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634530      PMCID: PMC1377253          DOI: 10.1086/301933

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  48 in total

1.  Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males.

Authors:  H Osaka; C Kawanishi; K Inoue; H Uesugi; K Hiroshi; K Nishiyama; Y Yamada; K Suzuki; S Kimura; K Kosaka
Journal:  Biochem Biophys Res Commun       Date:  1995-10-24       Impact factor: 3.575

Review 2.  The proteolipid protein gene.

Authors:  I R Griffiths; P Montague; P Dickinson
Journal:  Neuropathol Appl Neurobiol       Date:  1995-04       Impact factor: 8.090

3.  Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients.

Authors:  S L Christian; W P Robinson; B Huang; A Mutirangura; M R Line; M Nakao; U Surti; A Chakravarti; D H Ledbetter
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

4.  Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease.

Authors:  P Carango; V L Funanage; R E Quirós; C S Debruyn; H G Marks
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

5.  Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit.

Authors:  L Pentao; C A Wise; A C Chinault; P I Patel; J R Lupski
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

6.  X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.

Authors:  P Saugier-Veber; A Munnich; D Bonneau; J M Rozet; M Le Merrer; R Gil; O Boespflug-Tanguy
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

7.  Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. PMD Clinical Group.

Authors:  O Boespflug-Tanguy; C Mimault; J Melki; A Cavagna; G Giraud; D Pham Dinh; B Dastugue; A Dautigny
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

Review 8.  Genetics of Pelizaeus-Merzbacher disease.

Authors:  M E Hodes; V M Pratt; S R Dlouhy
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

9.  Dinucleotide repeat polymorphism in the proteolipoprotein (PLP) gene.

Authors:  C Mimault; F Cailloux; G Giraud; B Dastugue; O Boespflug-Tanguy
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

10.  Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene.

Authors:  T Kagawa; K Ikenaka; Y Inoue; S Kuriyama; T Tsujii; J Nakao; K Nakajima; J Aruga; H Okano; K Mikoshiba
Journal:  Neuron       Date:  1994-08       Impact factor: 17.173

View more
  24 in total

1.  Breaking away from home.

Authors:  L D Hudson
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

2.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

3.  High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease.

Authors:  B Bilir; Z Yapici; C Yalcinkaya; I Baris; C M B Carvalho; M Bartnik; B Ozes; M Eraksoy; J R Lupski; E Battaloglu
Journal:  Clin Genet       Date:  2012-02-20       Impact factor: 4.438

4.  Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females.

Authors:  Ken Inoue; Hitoshi Osaka; Virginia C Thurston; Joe T R Clarke; Akira Yoneyama; Lisa Rosenbarker; Thomas D Bird; M E Hodes; Lisa G Shaffer; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

5.  PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: Identification of one partial triplication and two partial deletions of PLP1.

Authors:  Patricia Combes; Marie-Noelle Bonnet-Dupeyron; Fernande Gauthier-Barichard; Raphael Schiffmann; Enrico Bertini; Diana Rodriguez; John A L Armour; Odile Boespflug-Tanguy; Catherine Vaurs-Barrière
Journal:  Neurogenetics       Date:  2006-01-17       Impact factor: 2.660

6.  Lower linkage disequilibrium at CNVs is due to both recurrent mutation and transposing duplications.

Authors:  Daniel R Schrider; Matthew W Hahn
Journal:  Mol Biol Evol       Date:  2010-01       Impact factor: 16.240

7.  Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome.

Authors:  M E Hodes; K Woodward; N B Spinner; B S Emanuel; A Enrico-Simon; J Kamholz; D Stambolian; E H Zackai; V M Pratt; I T Thomas; K Crandall; S R Dlouhy; S Malcolm
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

8.  Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene.

Authors:  K E Heath; I N Day; S E Humphries
Journal:  J Med Genet       Date:  2000-04       Impact factor: 6.318

9.  Efficient CNV breakpoint analysis reveals unexpected structural complexity and correlation of dosage-sensitive genes with clinical severity in genomic disorders.

Authors:  Ling Zhang; Jingmin Wang; Cheng Zhang; Dongxiao Li; Claudia M B Carvalho; Haoran Ji; Jianqiu Xiao; Ye Wu; Weichen Zhou; Hongyan Wang; Li Jin; Yang Luo; Xiru Wu; James R Lupski; Feng Zhang; Yuwu Jiang
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

10.  Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.

Authors:  Pawandeep Dhami; Alison J Coffey; Stephen Abbs; Joris R Vermeesch; Jan P Dumanski; Karen J Woodward; Robert M Andrews; Cordelia Langford; David Vetrie
Journal:  Am J Hum Genet       Date:  2005-03-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.